http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-994714-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec035b62b836fc6bb889bb726f97f6a7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 |
| filingDate | 1962-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a28d7439c0432534530368dc79a9535 |
| publicationDate | 1965-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-994714-A |
| titleOfInvention | Pharmaceutical compositions useful as general metabolic depressants |
| abstract | Pharmaceutical compositions having general metabolic depressant activity with concomitant hypnotic and analgesic effect comprise a carrier and a compound (or a salt thereof) of the general formula <FORM:0994714/A5-A6/1> wherein X represents a halogen atom; X1 represents a halogen atom, a thiocyanate or nitro group, or an alkyl or alkoxy group containing 1 to 4 carbon atoms; W represents a hydrogen atom, an alkoxy or alkylcarbonyloxy group containing up to 4 carbon atoms or an -NH.CO.COOCH3 group; and Z represents (a) a cyano group; (b) a nitrile oxide group; (c) a group of formula -CY = NOM or <FORM:0994714/A5-A6/2> wherein M represents a hydrogen atom, an acetyl, halogenated acetyl or ethoxycarbonyl group and Y represents a hydrogen or halogen atom, a cyano, thiocyanato, nitro, 4-methylphenylthio, phenylsulphonyl, hydroxyamino, hydrazino, phenylhydrazino, morpholino, piperidino or ureido group, or a group of formula NR1R2 (wherein R1 and R2 may be the same or different, each representing a hydrogen atom, a hydrocarbyl group containing 1-4 carbon atoms which group may bear halogen and/or hydroxy substituents; (d) a group of formula <FORM:0994714/A5-A6/3> or <FORM:0994714/A5-A6/4> wherein R represents a hydrogen atom, an unsubstituted or halogen substituted hydrocarbyl group containing 1 to 4 carbon atoms, or wherein -NR2 represents a morpholino group. They may be in conventional forms for oral and parenteral administration e.g. syrups, elixirs, powders, tablets and sterile solutions or suspensions comprising conventional excipients. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4091011-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4113880-A |
| priorityDate | 1962-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.